Cargando…
Diagnostic Leukapheresis Enables Reliable Transcriptomic Profiling of Single Circulating Tumor Cells to Characterize Inter-Cellular Heterogeneity in Terms of Endocrine Resistance
Circulating tumor cells (CTCs) hold great promise with regard to prognosis, treatment optimization, and monitoring of breast cancer patients. Single CTC transcriptome profiling might help reveal valuable information concerning intra-patient heterogeneity relevant to therapeutic interventions. In thi...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6679140/ https://www.ncbi.nlm.nih.gov/pubmed/31261643 http://dx.doi.org/10.3390/cancers11070903 |
_version_ | 1783441269408661504 |
---|---|
author | Reinhardt, Florian Franken, André Meier-Stiegen, Franziska Driemel, Christiane Stoecklein, Nikolas H. Fischer, Johannes C. Niederacher, Dieter Ruckhaeberle, Eugen Fehm, Tanja Neubauer, Hans |
author_facet | Reinhardt, Florian Franken, André Meier-Stiegen, Franziska Driemel, Christiane Stoecklein, Nikolas H. Fischer, Johannes C. Niederacher, Dieter Ruckhaeberle, Eugen Fehm, Tanja Neubauer, Hans |
author_sort | Reinhardt, Florian |
collection | PubMed |
description | Circulating tumor cells (CTCs) hold great promise with regard to prognosis, treatment optimization, and monitoring of breast cancer patients. Single CTC transcriptome profiling might help reveal valuable information concerning intra-patient heterogeneity relevant to therapeutic interventions. In this study, we combined Diagnostic Leukapheresis (DLA), which is a microfluidic enrichment using the Parsortix(TM) system, micromanipulation with CellCelector(TM) and subsequent single cell multi-marker transcriptome profiling. First, a PCR panel consisting of 30 different endocrine resistance and phenotypic marker genes was validated for single cell profiling by using different breast cancer cell lines. Second, this panel was applied to characterize uncultured and cultured CTCs, which were enriched from a cryopreserved DLA product obtained from a patient suffering from metastatic breast cancer resistant to endocrine therapy. Gene expression profiles of both CTC populations uncovered inter CTC heterogeneity for transcripts, which are associated with response or resistance to endocrine therapy (e.g., ESR1, HER2, FGFR1). Hierarchical clustering revealed CTC subpopulations with different expressions of transcripts regarding the CTCs’ differential phenotypes (EpCAM, CD44, CD24, MYC, MUC1) and of transcripts involved in endocrine signaling pathways (FOXO, PTEN). Moreover, ER-positive CTCs exhibited significant higher expression of Cyclin D1, which might be relevant for CDK4/6 inhibitor therapies. Overall, gene expression profiles of uncultured and cultured CTCs resulted in a partly combined grouping. Our findings demonstrate that multi-marker RNA profiling of enriched single uncultured CTCs and cultured CTCs form cryopreserved DLA samples may provide important insights into intra-patient heterogeneity relevant for targeted therapies and therapy resistance. |
format | Online Article Text |
id | pubmed-6679140 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-66791402019-08-19 Diagnostic Leukapheresis Enables Reliable Transcriptomic Profiling of Single Circulating Tumor Cells to Characterize Inter-Cellular Heterogeneity in Terms of Endocrine Resistance Reinhardt, Florian Franken, André Meier-Stiegen, Franziska Driemel, Christiane Stoecklein, Nikolas H. Fischer, Johannes C. Niederacher, Dieter Ruckhaeberle, Eugen Fehm, Tanja Neubauer, Hans Cancers (Basel) Article Circulating tumor cells (CTCs) hold great promise with regard to prognosis, treatment optimization, and monitoring of breast cancer patients. Single CTC transcriptome profiling might help reveal valuable information concerning intra-patient heterogeneity relevant to therapeutic interventions. In this study, we combined Diagnostic Leukapheresis (DLA), which is a microfluidic enrichment using the Parsortix(TM) system, micromanipulation with CellCelector(TM) and subsequent single cell multi-marker transcriptome profiling. First, a PCR panel consisting of 30 different endocrine resistance and phenotypic marker genes was validated for single cell profiling by using different breast cancer cell lines. Second, this panel was applied to characterize uncultured and cultured CTCs, which were enriched from a cryopreserved DLA product obtained from a patient suffering from metastatic breast cancer resistant to endocrine therapy. Gene expression profiles of both CTC populations uncovered inter CTC heterogeneity for transcripts, which are associated with response or resistance to endocrine therapy (e.g., ESR1, HER2, FGFR1). Hierarchical clustering revealed CTC subpopulations with different expressions of transcripts regarding the CTCs’ differential phenotypes (EpCAM, CD44, CD24, MYC, MUC1) and of transcripts involved in endocrine signaling pathways (FOXO, PTEN). Moreover, ER-positive CTCs exhibited significant higher expression of Cyclin D1, which might be relevant for CDK4/6 inhibitor therapies. Overall, gene expression profiles of uncultured and cultured CTCs resulted in a partly combined grouping. Our findings demonstrate that multi-marker RNA profiling of enriched single uncultured CTCs and cultured CTCs form cryopreserved DLA samples may provide important insights into intra-patient heterogeneity relevant for targeted therapies and therapy resistance. MDPI 2019-06-28 /pmc/articles/PMC6679140/ /pubmed/31261643 http://dx.doi.org/10.3390/cancers11070903 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Reinhardt, Florian Franken, André Meier-Stiegen, Franziska Driemel, Christiane Stoecklein, Nikolas H. Fischer, Johannes C. Niederacher, Dieter Ruckhaeberle, Eugen Fehm, Tanja Neubauer, Hans Diagnostic Leukapheresis Enables Reliable Transcriptomic Profiling of Single Circulating Tumor Cells to Characterize Inter-Cellular Heterogeneity in Terms of Endocrine Resistance |
title | Diagnostic Leukapheresis Enables Reliable Transcriptomic Profiling of Single Circulating Tumor Cells to Characterize Inter-Cellular Heterogeneity in Terms of Endocrine Resistance |
title_full | Diagnostic Leukapheresis Enables Reliable Transcriptomic Profiling of Single Circulating Tumor Cells to Characterize Inter-Cellular Heterogeneity in Terms of Endocrine Resistance |
title_fullStr | Diagnostic Leukapheresis Enables Reliable Transcriptomic Profiling of Single Circulating Tumor Cells to Characterize Inter-Cellular Heterogeneity in Terms of Endocrine Resistance |
title_full_unstemmed | Diagnostic Leukapheresis Enables Reliable Transcriptomic Profiling of Single Circulating Tumor Cells to Characterize Inter-Cellular Heterogeneity in Terms of Endocrine Resistance |
title_short | Diagnostic Leukapheresis Enables Reliable Transcriptomic Profiling of Single Circulating Tumor Cells to Characterize Inter-Cellular Heterogeneity in Terms of Endocrine Resistance |
title_sort | diagnostic leukapheresis enables reliable transcriptomic profiling of single circulating tumor cells to characterize inter-cellular heterogeneity in terms of endocrine resistance |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6679140/ https://www.ncbi.nlm.nih.gov/pubmed/31261643 http://dx.doi.org/10.3390/cancers11070903 |
work_keys_str_mv | AT reinhardtflorian diagnosticleukapheresisenablesreliabletranscriptomicprofilingofsinglecirculatingtumorcellstocharacterizeintercellularheterogeneityintermsofendocrineresistance AT frankenandre diagnosticleukapheresisenablesreliabletranscriptomicprofilingofsinglecirculatingtumorcellstocharacterizeintercellularheterogeneityintermsofendocrineresistance AT meierstiegenfranziska diagnosticleukapheresisenablesreliabletranscriptomicprofilingofsinglecirculatingtumorcellstocharacterizeintercellularheterogeneityintermsofendocrineresistance AT driemelchristiane diagnosticleukapheresisenablesreliabletranscriptomicprofilingofsinglecirculatingtumorcellstocharacterizeintercellularheterogeneityintermsofendocrineresistance AT stoeckleinnikolash diagnosticleukapheresisenablesreliabletranscriptomicprofilingofsinglecirculatingtumorcellstocharacterizeintercellularheterogeneityintermsofendocrineresistance AT fischerjohannesc diagnosticleukapheresisenablesreliabletranscriptomicprofilingofsinglecirculatingtumorcellstocharacterizeintercellularheterogeneityintermsofendocrineresistance AT niederacherdieter diagnosticleukapheresisenablesreliabletranscriptomicprofilingofsinglecirculatingtumorcellstocharacterizeintercellularheterogeneityintermsofendocrineresistance AT ruckhaeberleeugen diagnosticleukapheresisenablesreliabletranscriptomicprofilingofsinglecirculatingtumorcellstocharacterizeintercellularheterogeneityintermsofendocrineresistance AT fehmtanja diagnosticleukapheresisenablesreliabletranscriptomicprofilingofsinglecirculatingtumorcellstocharacterizeintercellularheterogeneityintermsofendocrineresistance AT neubauerhans diagnosticleukapheresisenablesreliabletranscriptomicprofilingofsinglecirculatingtumorcellstocharacterizeintercellularheterogeneityintermsofendocrineresistance |